In addition, IL-8 can induce fibroblasts in prostate stromal nodules to show significant myosin aggregation and α-SMA immune activity, suggesting that IL-8 acts as a regulator of BPH reactive stroma and is a potential therapeutic target [116]. The gene discussed is CXCL8; the disease is benign prostatic hyperplasia.